GR3004200T3 - - Google Patents

Info

Publication number
GR3004200T3
GR3004200T3 GR920400571T GR920400571T GR3004200T3 GR 3004200 T3 GR3004200 T3 GR 3004200T3 GR 920400571 T GR920400571 T GR 920400571T GR 920400571 T GR920400571 T GR 920400571T GR 3004200 T3 GR3004200 T3 GR 3004200T3
Authority
GR
Greece
Application number
GR920400571T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004200T3 publication Critical patent/GR3004200T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR920400571T 1987-02-02 1992-03-31 GR3004200T3 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
GR3004200T3 true GR3004200T3 (en:Method) 1993-03-31

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400571T GR3004200T3 (en:Method) 1987-02-02 1992-03-31

Country Status (42)

Country Link
US (1) US5036099A (en:Method)
EP (1) EP0277738B1 (en:Method)
JP (1) JPS63201184A (en:Method)
KR (1) KR900001422B1 (en:Method)
CN (1) CN1022324C (en:Method)
AP (1) AP52A (en:Method)
AR (1) AR243182A1 (en:Method)
AT (1) ATE73800T1 (en:Method)
AU (1) AU587736B2 (en:Method)
BG (1) BG51042A3 (en:Method)
CA (1) CA1335590C (en:Method)
CS (2) CS265250B2 (en:Method)
CY (1) CY1775A (en:Method)
DD (1) DD267490A5 (en:Method)
DE (1) DE3869149D1 (en:Method)
DK (1) DK44888A (en:Method)
EC (1) ECSP941082A (en:Method)
ES (1) ES2032955T3 (en:Method)
FI (1) FI89598C (en:Method)
GR (1) GR3004200T3 (en:Method)
HK (1) HK132695A (en:Method)
IE (1) IE60000B1 (en:Method)
IL (1) IL85277A (en:Method)
IN (1) IN171799B (en:Method)
IS (1) IS1533B (en:Method)
LV (1) LV10252B (en:Method)
MA (1) MA21171A1 (en:Method)
MY (1) MY102737A (en:Method)
NO (1) NO170581C (en:Method)
NZ (1) NZ223373A (en:Method)
OA (1) OA08710A (en:Method)
PH (1) PH26545A (en:Method)
PL (1) PL149550B1 (en:Method)
PT (1) PT86675B (en:Method)
RO (1) RO105052B1 (en:Method)
RU (1) RU2011381C1 (en:Method)
SG (1) SG27994G (en:Method)
SI (1) SI8810183A8 (en:Method)
UA (1) UA25898A1 (en:Method)
WO (1) WO1988005656A1 (en:Method)
YU (1) YU46766B (en:Method)
ZA (1) ZA88679B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
SK590689A3 (en) * 1988-10-18 1996-03-06 Pfizer 3-aryl-2-oxindole-1-carboxamides and method of their preparation
EP0365194B1 (en) * 1988-10-18 1995-08-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) * 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) * 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
EP3703583B1 (en) 2017-11-02 2025-10-15 Accurate Medical Therapeutics Ltd. Embolization catheter with integral filter
US12433600B2 (en) 2019-05-23 2025-10-07 Argon Medical Devices, Inc. Embolization catheter for reflux free delivery of microspheres

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
GR850310B (en:Method) * 1984-02-07 1985-06-05 Pfizer
EP0155828B1 (en) * 1984-03-19 1990-09-19 Pfizer Inc. Process for making 2-oxindole-1-carboxamides and intermediates therefor
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
ZA88679B (en) 1989-09-27
AU1116088A (en) 1988-08-04
CN1022324C (zh) 1993-10-06
ES2032955T3 (es) 1996-07-16
CN88100555A (zh) 1988-08-17
CA1335590C (en) 1995-05-16
RU2011381C1 (ru) 1994-04-30
NO170581B (no) 1992-07-27
UA25898A1 (uk) 1999-02-26
NO884329D0 (no) 1988-09-29
FI89598B (fi) 1993-07-15
RO105052B1 (en) 1994-12-01
LV10252A (lv) 1994-10-20
YU18388A (en) 1989-10-31
FI893647A0 (fi) 1989-08-01
NZ223373A (en) 1989-06-28
DK44888A (da) 1988-08-03
EP0277738B1 (en) 1992-03-18
CY1775A (en) 1996-04-05
IS1533B (is) 1994-01-28
ATE73800T1 (de) 1992-04-15
SG27994G (en) 1994-10-14
IL85277A (en) 1994-02-27
AP8800081A0 (en) 1987-11-01
DE3869149D1 (de) 1992-04-23
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
US5036099A (en) 1991-07-30
IN171799B (en:Method) 1993-01-09
ECSP941082A (es) 1994-12-15
HK132695A (en) 1995-09-01
AU587736B2 (en) 1989-08-24
IL85277A0 (en) 1988-07-31
AP52A (en) 1989-09-16
SI8810183A8 (sl) 1996-08-31
DD267490A5 (de) 1989-05-03
MA21171A1 (fr) 1988-10-01
CS354191A3 (en) 1992-04-15
FI89598C (fi) 1993-10-25
NO170581C (no) 1992-11-04
WO1988005656A1 (en) 1988-08-11
NO884329L (no) 1988-09-29
KR880009961A (ko) 1988-10-06
CS265250B2 (en) 1989-10-13
KR900001422B1 (ko) 1990-03-09
YU46766B (sh) 1994-05-10
IE880269L (en) 1988-08-02
MY102737A (en) 1992-09-30
BG51042A3 (bg) 1993-01-15
PT86675A (pt) 1988-03-01
CS64888A2 (en) 1988-08-16
JPH0576945B2 (en:Method) 1993-10-25
DK44888D0 (da) 1988-01-29
PL149550B1 (en) 1990-02-28
PT86675B (pt) 1992-07-31
IE60000B1 (en) 1994-05-18
AR243182A1 (es) 1993-07-30
IS3309A7 (is) 1988-08-03
PL270415A1 (en) 1988-12-08
PH26545A (en) 1992-08-19
OA08710A (fr) 1989-03-31
EP0277738A1 (en) 1988-08-10

Similar Documents

Publication Publication Date Title
GR3004200T3 (en:Method)
IN170793B (en:Method)
IN169553B (en:Method)
DE3875906T (en:Method)
IN171151B (en:Method)
IN170711B (en:Method)
ATA244887A (en:Method)
AU6354986A (en:Method)
IN171606B (en:Method)
AU6081986A (en:Method)
AU7551587A (en:Method)
AU6391486A (en:Method)
AU7621687A (en:Method)
IN169174B (en:Method)
AU7537187A (en:Method)
AU6957887A (en:Method)
AU6539686A (en:Method)
IN165498B (en:Method)
IN165069B (en:Method)
ZA879709B (en:Method)
BG44887A1 (en:Method)
BG44573A1 (en:Method)
BG44755A1 (en:Method)
BG44858A1 (en:Method)
BG44591A1 (en:Method)